Filter By
SUPER TADARISE is a dual-action oral treatment combining Tadalafil 20mg and Dapoxetine 60mg, designed to help men overcome both erectile dysfunction (ED) and premature ejaculation (PE). Manufactured under...
SUPER P-FORCE is a dual-action oral tablet formulated to treat both erectile dysfunction (ED) and premature ejaculation (PE) in men. Combining Sildenafil Citrate 100mg and Dapoxetine 60mg, it...
Super P-Force Oral Jelly is a fast-acting dual-action treatment designed for men facing erectile dysfunction (ED) and premature ejaculation (PE). This jelly-based formulation combines Sildenafil Citrate (100 mg)...
Poxet 90 is a high-dose treatment for premature ejaculation (PE) in men, containing Dapoxetine 90mg. It helps significantly delay ejaculation, improve sexual performance, and increase satisfaction. Manufactured under...
Poxet 60 is a high-strength oral treatment containing Dapoxetine 60mg, clinically formulated to manage premature ejaculation (PE) in adult men. It enhances ejaculation control, prolongs intercourse duration, and...
Poxet 30 is an effective treatment for premature ejaculation (PE) in men. Containing Dapoxetine 30mg, it helps improve control over ejaculation, increase sexual satisfaction, and extend the duration...
MALEGRA DXT is a dual-purpose oral tablet that combines Sildenafil Citrate 100mg with Duloxetine 30mg for the treatment of both erectile dysfunction (ED) and premature ejaculation (PE) in...
MALEGRA DXT PLUS is a dual-action therapy combining Sildenafil Citrate 100mg and Duloxetine 60mg to treat both erectile dysfunction (ED) and premature ejaculation (PE). This combination improves erection...
EXTRA SUPER TADARISE is a powerful combination of Tadalafil 40mg and Dapoxetine 60mg, used for the dual treatment of erectile dysfunction (ED) and premature ejaculation (PE) in men.Manufactured...
EXTRA SUPER AVANA combines Avanafil 200mg (for erectile dysfunction) and Dapoxetine 60mg (for premature ejaculation) in one powerful dual-action tablet.Manufactured under WHO-GMP, ISO 9001:2015, and FDA-export compliant conditions,...
